Literature DB >> 7298260

Hermansky-Pudlak syndrome: albinism with lipofuscin storage.

W R Fagadau, M H Heinemann, E Cotlier.   

Abstract

The Hermansky-Pudlak Syndrome, a "tyrosinase positive' form of oculocutaneous albinism, is a triad comprising albinism, a hemorrhagic diathesis and ceroid-lipofuscin storage. A pedigree is presented showing consanguinity with a pattern of pseudodominance. Electroretinography in two isolated Hermansky-Pudlak subjects was distinctly abnormal, showing decreased rod and cone responses (as well as abnormal flicker fusion responses) in one patient, and reduced photopic and scotopic responses in another. The decreased ERG responses are discussed with reference to the known retinal abnormalities in both generalized oculocutaneous albinism and Batten's disease, another ceroid-lipofuscin storage disorder.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7298260     DOI: 10.1007/bf00139585

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  46 in total

Review 1.  Albinism.

Authors:  J François
Journal:  Ophthalmologica       Date:  1979       Impact factor: 3.250

2.  The platelet defect associated with albumism.

Authors:  R M Hardisty; D C Mills; K Ketsa-Ard
Journal:  Br J Haematol       Date:  1972-12       Impact factor: 6.998

3.  Effects of normal and aspirin platelets on defective secondary aggregation in the Hermansky-Pudlak syndrome. A test for storage pool deficient platelets.

Authors:  J G White; C J Witkop
Journal:  Am J Pathol       Date:  1972-07       Impact factor: 4.307

4.  Demonstration of tyrosinase in the adult bovine uveal tract and retinal pigment epithelium.

Authors:  T P Dryja; M O'Neil-Dryja; J M Pawelek; D M Albert
Journal:  Invest Ophthalmol Vis Sci       Date:  1978-06       Impact factor: 4.799

5.  Electrical activity of the eye in high myopia.

Authors:  R K Blach; B Jay; H Kolb
Journal:  Br J Ophthalmol       Date:  1966-11       Impact factor: 4.638

6.  Human albinism. Light and electron microscopy study.

Authors:  A B Fulton; D M Albert; J L Craft
Journal:  Arch Ophthalmol       Date:  1978-02

7.  Lipofuscin of human retinal pigment epithelium.

Authors:  L Feeney-Burns; E R Berman; H Rothman
Journal:  Am J Ophthalmol       Date:  1980-12       Impact factor: 5.258

8.  Studies of platelet 5-hydroxytryptamine (serotonin) in storage pool disease and albinism.

Authors:  H J Weiss; T B Tschopp; J Rogers; H Brand
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

9.  The effect of salicylates on the hemostatic properties of platelets in man.

Authors:  H J Weiss; L M Aledort; S Kochwa
Journal:  J Clin Invest       Date:  1968-09       Impact factor: 14.808

10.  Storage pool disease: comparative fluorescence microscopical, cytochemical and biochemical studies on amine-storing organelles of human blood platelets.

Authors:  H P Lorez; J G Richards; M Da Prada; G B Picotti; F I Pareti; A Capitanio; P M Mannucci
Journal:  Br J Haematol       Date:  1979-10       Impact factor: 6.998

View more
  4 in total

1.  Vision in albinism.

Authors:  C G Summers
Journal:  Trans Am Ophthalmol Soc       Date:  1996

2.  Albinism with haemorrhagic diathesis: Hermansky-Pudlak syndrome.

Authors:  P E Kinnear; E G Tuddenham
Journal:  Br J Ophthalmol       Date:  1985-12       Impact factor: 4.638

3.  Lipofuscin accumulation and autophagy in glaucomatous human lamina cribrosa cells.

Authors:  Elizabeth M McElnea; Emily Hughes; Aloysius McGoldrick; Amanda McCann; Barry Quill; Neil Docherty; Mustapha Irnaten; Michael Farrell; Abbot F Clark; Colm J O'Brien; Deborah M Wallace
Journal:  BMC Ophthalmol       Date:  2014-12-02       Impact factor: 2.209

4.  Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7.

Authors:  Giovanni Luca Romano; Chiara Bianca Maria Platania; Gian Marco Leggio; Sebastiano Alfio Torrisi; Salvatore Giunta; Salvatore Salomone; Michele Purrello; Marco Ragusa; Cristina Barbagallo; Frank J Giblin; Rosa Mastrogiacomo; Francesca Managò; Maurizio Cammalleri; Francesco Papaleo; Filippo Drago; Claudio Bucolo
Journal:  Sci Rep       Date:  2020-03-04       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.